Andrea C Baines

8PUBLICATIONS
25CO-AUTHORS
Haematological tumoursSequence analysisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2025
The BCR-SEQC initiative.

Rittika Mallik, Rebecca Kusko, Andrea C Baines

|Oct 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma.

Andrea C Baines, Bindu Kanapuru, Jay Zhao

|Mar 09, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.

Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon

|Jun 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma.

Andrea C Baines, Rachel Ershler, Bindu Kanapuru

Pageof 2